PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...
LongBio is proud to announce that the National Medical Products Administration (NMPA, China) has approved the Investigational New Drug (IND) application for LP-003, the company's next-generation ...
Health Recovery Solutions (HRS) is proud to announce a strategic partnership with The Queen's Health Systems to launch a comprehensive Remote Patient Monitoring (RPM) program through the Native ...